| UniProt ID | BRCC3_HUMAN | |
|---|---|---|
| UniProt AC | P46736 | |
| Protein Name | Lys-63-specific deubiquitinase BRCC36 | |
| Gene Name | BRCC3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 316 | |
| Subcellular Localization | Nucleus . Cytoplasm . Cytoplasm, cytoskeleton, spindle pole . Localizes at sites of DNA damage at double-strand breaks (DSBs) (PubMed:20656690, PubMed:26344097). Interaction with ABRAXAS2 retains BRCC3 in the cytoplasm (PubMed:20656690). | |
| Protein Description | Metalloprotease that specifically cleaves 'Lys-63'-linked polyubiquitin chains. [PubMed: 19214193] | |
| Protein Sequence | MAVQVVQAVQAVHLESDAFLVCLNHALSTEKEEVMGLCIGELNDDTRSDSKFAYTGTEMRTVAEKVDAVRIVHIHSVIILRRSDKRKDRVEISPEQLSAASTEAERLAELTGRPMRVVGWYHSHPHITVWPSHVDVRTQAMYQMMDQGFVGLIFSCFIEDKNTKTGRVLYTCFQSIQAQKSSESLHGPRDFWSSSQHISIEGQKEEERYERIEIPIHIVPHVTIGKVCLESAVELPKILCQEEQDAYRRIHSLTHLDSVTKIHNGSVFTKNLCSQMSAVSGPLLQWLEDRLEQNQQHLQELQQEKEELMQELSSLE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAVQVVQAV ------CHHHHHHHH | 10.64 | - | |
| 28 | Phosphorylation | VCLNHALSTEKEEVM HHHHHHCCCCCHHHH | 34.99 | 20068231 | |
| 51 | Ubiquitination | DDTRSDSKFAYTGTE CCCCCCCCCCCCCCH | 38.72 | 27667366 | |
| 51 (in isoform 5) | Ubiquitination | - | 38.72 | 21890473 | |
| 51 (in isoform 1) | Ubiquitination | - | 38.72 | 21890473 | |
| 51 (in isoform 2) | Ubiquitination | - | 38.72 | 21890473 | |
| 52 (in isoform 3) | Ubiquitination | - | 7.91 | 21890473 | |
| 52 | Ubiquitination | DTRSDSKFAYTGTEM CCCCCCCCCCCCCHH | 7.91 | 23000965 | |
| 54 | Phosphorylation | RSDSKFAYTGTEMRT CCCCCCCCCCCHHHH | 14.61 | 21945579 | |
| 55 | Phosphorylation | SDSKFAYTGTEMRTV CCCCCCCCCCHHHHH | 33.91 | 21945579 | |
| 55 (in isoform 3) | Phosphorylation | - | 33.91 | 25627689 | |
| 61 | Phosphorylation | YTGTEMRTVAEKVDA CCCCHHHHHHHHCCE | 23.82 | 20068231 | |
| 65 (in isoform 5) | Ubiquitination | - | 35.36 | 21890473 | |
| 65 (in isoform 1) | Ubiquitination | - | 35.36 | 21890473 | |
| 65 (in isoform 2) | Ubiquitination | - | 35.36 | 21890473 | |
| 65 | Ubiquitination | EMRTVAEKVDAVRIV HHHHHHHHCCEEEEE | 35.36 | 21906983 | |
| 66 (in isoform 3) | Ubiquitination | - | 4.26 | 21890473 | |
| 66 | Ubiquitination | MRTVAEKVDAVRIVH HHHHHHHCCEEEEEE | 4.26 | 27667366 | |
| 142 | Phosphorylation | DVRTQAMYQMMDQGF HHHHHHHHHHHHCCC | 9.03 | 24043423 | |
| 155 | Phosphorylation | GFVGLIFSCFIEDKN CCHHEEEEEEEECCC | 10.92 | 24043423 | |
| 156 (in isoform 4) | Ubiquitination | - | 2.51 | 21890473 | |
| 180 | Ubiquitination | FQSIQAQKSSESLHG HHHHHHHHCCCCCCC | 59.99 | 23000965 | |
| 180 (in isoform 1) | Ubiquitination | - | 59.99 | 21890473 | |
| 180 (in isoform 2) | Ubiquitination | - | 59.99 | 21890473 | |
| 181 | Ubiquitination | QSIQAQKSSESLHGP HHHHHHHCCCCCCCC | 27.53 | 23000965 | |
| 181 (in isoform 3) | Ubiquitination | - | 27.53 | 21890473 | |
| 199 | Phosphorylation | WSSSQHISIEGQKEE CCCCCCEEECCCCHH | 16.68 | 27251275 | |
| 201 | Ubiquitination | SSQHISIEGQKEEER CCCCEEECCCCHHHH | 49.10 | 21963094 | |
| 202 | Ubiquitination | SQHISIEGQKEEERY CCCEEECCCCHHHHH | 42.04 | 21963094 | |
| 204 | Ubiquitination | HISIEGQKEEERYER CEEECCCCHHHHHHH | 77.33 | - | |
| 212 | Ubiquitination | EEERYERIEIPIHIV HHHHHHHEECCEEEC | 3.63 | 29967540 | |
| 213 | Ubiquitination | EERYERIEIPIHIVP HHHHHHEECCEEECC | 49.27 | 29967540 | |
| 223 | Phosphorylation | IHIVPHVTIGKVCLE EEECCCCCCCHHHHH | 22.45 | 20068231 | |
| 226 | Ubiquitination | VPHVTIGKVCLESAV CCCCCCCHHHHHHHH | 26.40 | 21963094 | |
| 227 | Ubiquitination | PHVTIGKVCLESAVE CCCCCCHHHHHHHHH | 3.67 | 21963094 | |
| 231 | Phosphorylation | IGKVCLESAVELPKI CCHHHHHHHHHHCHH | 25.35 | 20068231 | |
| 236 | Ubiquitination | LESAVELPKILCQEE HHHHHHHCHHHCHHH | 14.24 | 21963094 | |
| 237 | Ubiquitination | ESAVELPKILCQEEQ HHHHHHCHHHCHHHH | 62.02 | 21963094 | |
| 247 | Phosphorylation | CQEEQDAYRRIHSLT CHHHHHHHHHHHHHH | 14.55 | - | |
| 252 | Phosphorylation | DAYRRIHSLTHLDSV HHHHHHHHHHCHHHC | 32.37 | 23312004 | |
| 254 | Phosphorylation | YRRIHSLTHLDSVTK HHHHHHHHCHHHCEE | 24.33 | 23312004 | |
| 258 | Phosphorylation | HSLTHLDSVTKIHNG HHHHCHHHCEEEECC | 37.74 | 17525341 | |
| 260 | Phosphorylation | LTHLDSVTKIHNGSV HHCHHHCEEEECCCE | 28.38 | 25627689 | |
| 261 | Ubiquitination | THLDSVTKIHNGSVF HCHHHCEEEECCCEE | 39.55 | 21963094 | |
| 262 | Ubiquitination | HLDSVTKIHNGSVFT CHHHCEEEECCCEEC | 1.92 | 21963094 | |
| 280 | Ubiquitination | CSQMSAVSGPLLQWL HHHHHHHHHHHHHHH | 34.12 | 21963094 | |
| 281 | Ubiquitination | SQMSAVSGPLLQWLE HHHHHHHHHHHHHHH | 15.41 | 21963094 | |
| 305 | Acetylation | LQELQQEKEELMQEL HHHHHHHHHHHHHHH | 52.75 | 26051181 | |
| 305 | Ubiquitination | LQELQQEKEELMQEL HHHHHHHHHHHHHHH | 52.75 | 21963094 | |
| 306 | Ubiquitination | QELQQEKEELMQELS HHHHHHHHHHHHHHH | 56.46 | 21963094 | |
| 313 | Phosphorylation | EELMQELSSLE---- HHHHHHHHCCC---- | 31.93 | 29514088 | |
| 314 | Phosphorylation | ELMQELSSLE----- HHHHHHHCCC----- | 49.49 | 29514088 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BRCC3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BRCC3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BRCC3_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...